The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 04, 2025
Filed:
Mar. 15, 2024
Pharmathen S.a., Pallini-Attikis, GR;
Evangelos Karavas, Pallini Attikis, GR;
Efthymios Koutris, Pallini Attikis, GR;
Vasiliki Samara, Pallini Attikis, GR;
Ioanna Koutri, Pallini Attikis, GR;
Anastasia Kalaskani, Pallini Attikis, GR;
Lida Kalantzi, Pallini Attikis, GR;
Andreas Kakouris, Pallini Attikis, GR;
Amalia Diakidou, Pallini Attikis, GR;
George Gotzamanis, Pallini Attikis, GR;
Zaharias Georgousis, Pallini Attikis, GR;
Manolis Fousteris, Pallini Attikis, GR;
PHARMATHEN S. A., Pallini-Attikis, GR;
Abstract
A powder including Valaciclovir or pharmaceutical acceptable salt or derivative thereof and an ion exchange resin. The Valaciclovir is in complex with the ion exchange resin forming Drug-Resin complex (DRC) particles, and each DRC particle comprises hydrogen bonds between the ion exchange resin and a cationic center of Valaciclovir. The ratio of Valaciclovir to the ion exchange resin in the DRC particle is 1:0.5. The powder further includes a suspending agent and a pH agent, and the suspending agent forms a film around each DRC particle and the film decreases interparticle attraction. The powder is configured to be reconstituted with an aqueous diluent as suspension for oral administration.